SIK3 and ovarian cancer: From our in vitro studies, we found that the ovarian cancer cell lines SKOV3 and OVCAR4 with SIK3 knockdown displayed significant chemoresistance to Taxol/cisplatin, which was specifically associated with the upregulation of ABCG2 (Figure 4 and Figure 5).